Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


Delayed Quote. Delayed London Stock Exchange - 09/24 11:35:14 am
8845 GBX   +2.04%
09/24Health Care Stocks Retreat Friday
09/24Eurostoxx 50 : European stocks slip on Evergrande woes, weak German business morale
09/24European ADRs Move Lower in Friday Trading
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

After vaccination burnout, Delta variant spurs countries to speed up shots

07/13/2021 | 06:00am EDT

July 13 (Reuters) - The daily pace of COVID vaccinations has increased in about a dozen countries due to the arrival of the more contagious Delta variant and governments expanding their vaccination drives, a data analysis by Reuters found.

Israel's rate of vaccinations has seen a sharp pickup. The Netherlands, Norway, Portugal, Saudi Arabia, Singapore and Spain are all vaccinating at their fastest speed to date. Belgium, Denmark, Finland and Sweden are not far behind.

But it is a different story in the United States. At its current, declining pace, 70% of the U.S. population will not receive a first dose of vaccine until Dec. 1, according to the Reuters analysis of Our World in Data vaccination figures https://ourworldindata.org/covid-vaccinations.

At the current pace, Canada, Chile, the United Kingdom, and eight others will reach that benchmark before the end of the month. And if the current pace is maintained, five more countries will hit 70% by the end of August. Those dates could change depending on many factors, including approvals to vaccinate younger children. (Graphic on vaccinations) https://tmsnrt.rs/2TbE5vy


In Israel the vaccination rate had plateaued in April as new COVID infections were on a months-long steady decline. But when the arrival of Delta brought a spike of cases in June, the government jumped in quickly with a new campaign urging teenagers to get the shot and parents to vaccinate their children aged 12 to 15.

In many countries, vaccination drives slowed before reaching 70% or more of the population - a threshold some experts say could help largely curb COVID-19 transmission through so-called herd immunity, when combined with people who developed immunity following an infection. (Graphic on global vaccinations) https://tmsnrt.rs/3tUM8ta

The ability of the coronavirus to mutate quickly into new variants, such as Delta, that reduce the effectiveness of vaccines has cast doubt on whether herd immunity can be achieved. However, various governments have still set national vaccination goals close to that number to encourage citizens to get inoculated. The European Union, for instance, has distributed enough vaccines for 70% of its population.

In some places, regulators have just recently authorized use of the shots in 12 to 15 year olds; in others, supply is catching up with demand.

Many of those countries had initially focused on giving shots to older populations and other high-risk groups. The Pfizer/BioNTech vaccine has been authorized by the U.S. and European Union for people aged 12 and over, but others such as AstraZeneca are only available to adults.

With the spread of the Delta variant, countries are trying to reignite their campaigns by overcoming skepticism about the vaccine and misconceptions that the young do not need a shot.

Heidi Larson, director of the international Vaccine Confidence Project and a professor at the London School of Hygiene and Tropical Medicine, said a rise in vaccinations due to Delta variant concerns may have been held back by changes seen as signalling an end to the pandemic, such as lifting mask mandates and travel bans.

"We're giving a lot of mixed messages right now," Larson said. Israel is an exception, she said. It has reimposed measures such as requiring mask use indoors.

While a decline in vaccination rates is to be expected, it has created pockets where groups including children, the elderly and homeless remain at risk, experts say.

"A deceleration of vaccination in itself is a logical phenomenon," said Vincent Marechal, a senior virologist with France's Sorbonne University. But slowing down too early opens the door to the virus spreading - mostly among children - and evolving to become more dangerous for them.


Portugal, where the Delta variant accounts for more than 90% of cases, has the highest number of new cases in the European Unions since mid-June. It has also doubled its pace of vaccinations from a low of around 60,000 inoculations per day, in part by including 18 to 29 year olds. (Graphic on global cases) https://tmsnrt.rs/34pvUyi

In Singapore, the rate of vaccinations has recently gone up after opening its vaccination program to people aged 12 to 39 years old. It also hastened the delivery of vaccine supplies to help it accelerate the rollout.

In Britain, where 87% of adults have received at least one dose of COVID-19 vaccine, the government stepped up its target to have all adults vaccinated by July 19, when its COVID restrictions are slated to be lifted. It has begun giving second shots sooner as well to fight the Delta variant.


In France, where 53.3% of the adult population has received one dose of a vaccine and 41.3% two doses or a single-dose shot, authorities are ramping up outreach to those who have not made vaccination appointments.

"We are indeed hitting a glass ceiling and trying to come up every day with ideas, and the good news is we are seeing a very recent pick up in bookings," a source close to the health ministry said last week.

The source added the government was still hoping to see 40 million of adults receive a first dose by the end of August versus 35.9 million as of July 12.

France is about to open temporary vaccination centres at cultural venues across the country such as in Avignon, home to a world-famous theatre festival, and vaccination buses will tour the Bordeaux wine region of Gironde to catch seasonal workers.

COVID-19 jabs will be mandatory for France's health workers and anyone wanting to get into a cinema or board a train will soon need to show proof of vaccination or a negative test under new rules announced by President Emmanuel Macron on Monday.

In the United States, where young people have been eligible since April, vaccinations are stagnant. The Biden administration missed its goal of 70% of adults having had at least one COVID-19 shot by July 4 and has struggled to reach 50% fully vaccinated even as it has warned of outbreaks due to the Delta variant.

Younger people have lagged older ones in seeking vaccines while shots among Black and Hispanic Americans have trailed those of Asian and white Americans, according to data from the Centers for Disease Control and Prevention.

"Whether governments throw in incentives or coercive measures, there is no magical solution," said Martin Blachier, an epidemiologist with Paris-based healthcare data analysis firm Public Health Expertise. "Some will just not get the vaccine."

(Reporting by Matthias Blamont in Paris, Michael Erman in New York and Maayan Lubell in Jerusalem; Additional reporting by Francesco Guarascio in Brussels, Nikolaj Skydsgaard in Copenhagen, Sergio Goncalves in Lisbon, Alistair Smout in London, Lin Chen in Singapore, Chris Canipe in Kansas City, Missouri, Jitesh Chowdhury in Bengalaru; editing by Jon McLure, Caroline Humer and Lisa Shumaker)

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 2.04% 8845 Delayed Quote.20.77%
JONJEE HI-TECH INDUSTRIAL & COMMERCIAL HOLDING CO., LTD. 8.36% 31.87 End-of-day quote.-52.18%
MSCI SINGAPORE (GDTR) -0.56% 6540.383 Real-time Quote.13.02%
WULIANGYE YIBIN CO.,LTD. 3.14% 200.52 End-of-day quote.-31.29%
All news about ASTRAZENECA PLC
09/24Health Care Stocks Retreat Friday
09/24Eurostoxx 50 : European stocks slip on Evergrande woes, weak German business morale
09/24European ADRs Move Lower in Friday Trading
09/24ASTRAZENECA : Receives a Buy rating from Barclays
09/24Wall Street Tumbles Pre-Bell, Evergrande Risks Resurface
09/24Health Care Stocks Slip Pre-Bell Friday
09/24IMPERIAL COLLEGE LONDON : Imperial RNA technology to be developed by VaxEquity with AstraZ..
09/24DEPARTMENT OF HEALTH AND SOCIAL CARE : check the rules for travel to England from abroad
09/24ASTRAZENECA : Lynparza in combination with abiraterone significantly delayed disease progr..
09/24ASTRAZENECA : LYNPARZA« (olaparib) in combination with abiraterone significantly delayed d..
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 401 M - -
Net income 2021 5 006 M - -
Net Debt 2021 24 250 M - -
P/E ratio 2021 33,8x
Yield 2021 2,33%
Capitalization 187 B 187 B -
EV / Sales 2021 5,98x
EV / Sales 2022 4,85x
Nbr of Employees 76 100
Free-Float 96,3%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 120,91 $
Average target price 136,24 $
Spread / Average Target 12,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC20.77%187 304
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485